Literature DB >> 1708474

Human neuroblastoma cells treated with aluminium express an epitope associated with Alzheimer's disease neurofibrillary tangles.

S P Guy1, D Jones, D M Mann, R F Itzhaki.   

Abstract

A number of studies have implicated aluminium as a possible factor in the pathogenesis of Alzheimer's disease (AD). Following an examination of the uptake of aluminium by human neuroblastoma cells in culture, treated with a range of concentrations of aluminium complexed with ethylene-diaminetetra-acetic acid (EDTA), we have now carried out an immunocytochemical study. Using an antibody to phosphorylated tau protein, which reacts specifically with AD neurofibrillary tangles (NFT), we have found that after treatment periods of 16 days to 8 weeks with aluminium-EDTA, the cells show positive staining with this antibody. No such reaction was detected in cells grown in medium alone, nor in aluminium-EDTA-treated cells subjected to the same immunocytochemical procedure but without added primary antibody. Cells grown in medium plus EDTA, which contains a low level of aluminium contamination, showed a slight reaction. Our system may provide a suitable model for studying the early changes which lead to NFT formation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1708474     DOI: 10.1016/0304-3940(91)90676-k

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  10 in total

1.  Run-on gene transcription in human neocortical nuclei. Inhibition by nanomolar aluminum and implications for neurodegenerative disease.

Authors:  W J Lukiw; H J LeBlanc; L A Carver; D R McLachlan; N G Bazan
Journal:  J Mol Neurosci       Date:  1998-08       Impact factor: 3.444

2.  Phosphorylation sensitizes microtubule-associated protein tau to Al(3+)-induced aggregation.

Authors:  W Li; K K Ma; W Sun; H K Paudel
Journal:  Neurochem Res       Date:  1998-12       Impact factor: 3.996

3.  Hippocampal tin, aluminum and zinc in Alzheimer's disease.

Authors:  F M Corrigan; G P Reynolds; N I Ward
Journal:  Biometals       Date:  1993       Impact factor: 2.949

4.  Alzheimer's disease-type neurofibrillary degeneration in verrucose dysplasias of the cerebral cortex.

Authors:  M A Morán; A Probst; C Navarro; P Gómez-Ramos
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

Review 5.  Would decreased aluminum ingestion reduce the incidence of Alzheimer's disease?

Authors:  D R McLachlan; T P Kruck; W J Lukiw; S S Krishnan
Journal:  CMAJ       Date:  1991-10-01       Impact factor: 8.262

Review 6.  Possible factors in the etiology of Alzheimer's disease.

Authors:  R F Itzhaki
Journal:  Mol Neurobiol       Date:  1994 Aug-Dec       Impact factor: 5.590

7.  Link between Aluminum and the Pathogenesis of Alzheimer's Disease: The Integration of the Aluminum and Amyloid Cascade Hypotheses.

Authors:  Masahiro Kawahara; Midori Kato-Negishi
Journal:  Int J Alzheimers Dis       Date:  2011-03-08

8.  Identification of Cerebral Metal Ion Imbalance in the Brain of Aging Octodon degus.

Authors:  Nady Braidy; Anne Poljak; Chris Marjo; Helen Rutlidge; Anne Rich; Bat-Erdene Jugder; Tharusha Jayasena; Nibaldo C Inestrosa; Perminder S Sachdev
Journal:  Front Aging Neurosci       Date:  2017-03-29       Impact factor: 5.750

Review 9.  Is aluminum exposure a risk factor for neurological disorders?

Authors:  Elif Inan-Eroglu; Aylin Ayaz
Journal:  J Res Med Sci       Date:  2018-06-06       Impact factor: 1.852

10.  Tau interactome analyses in CRISPR-Cas9 engineered neuronal cells reveal ATPase-dependent binding of wild-type but not P301L Tau to non-muscle myosins.

Authors:  Xinzhu Wang; Declan Williams; Iris Müller; Mackenzie Lemieux; Ramona Dukart; Isabella B L Maia; Hansen Wang; Amanda L Woerman; Gerold Schmitt-Ulms
Journal:  Sci Rep       Date:  2019-11-07       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.